Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aequus Pharmaceuticals Inc (AQS.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX-V]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX-V]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 14,150
  • Shares Outstanding, K 72,562
  • Annual Sales, $ 0 K
  • Annual Income, $ N/A
  • 36-Month Beta -0.90
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.14
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings -0.01 on 09/30/17
  • Next Earnings Date 09/04/18
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.180 +13.89%
on 07/19/18
0.225 -8.89%
on 06/25/18
unch (unch)
since 06/22/18
3-Month
0.180 +13.89%
on 07/19/18
0.300 -31.67%
on 05/04/18
-0.045 (-18.00%)
since 04/23/18
52-Week
0.135 +51.85%
on 09/08/17
0.450 -54.44%
on 01/11/18
-0.015 (-6.82%)
since 07/21/17

Most Recent Stories

More News
Aequus Announces Proposed $800,000 Equity Financing To Next Edge Biotech Plus Fund

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES

AQS.VN : 0.205 (+5.13%)
AQSZF : 0.1529 (+1.93%)
Aequus Extends and Enhances Commercial Agreement to Promote Vistitan in Canada

Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) ("Aequus" or the "Company"), is pleased to announce that it has agreed to new terms for its promotional service agreement with Sandoz on Vistitan(TM)...

AQS.VN : 0.205 (+5.13%)
AQSZF : 0.1529 (+1.93%)
Aequus and Corium Join Forces to Advance Anti-Nausea Transdermal Patch

Key Highlights

AQS.VN : 0.205 (+5.13%)
AQSZF : 0.1529 (+1.93%)
Aequus Announces First Canadian Cataract Procedures Using Zepto Capsulotomy System

Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) ("Aequus" or the "Company"), is pleased to announce the first four cataract procedures in Canada using the ZeptoCapsulotomy System ("Zepto"), a precision...

AQS.VN : 0.205 (+5.13%)
AQSZF : 0.1529 (+1.93%)
Aequus Provides First Quarter 2018 Financial and Corporate Highlights

Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today...

AQS.VN : 0.205 (+5.13%)
AQSZF : 0.1529 (+1.93%)
Aequus Announces Official Launch of Zepto Capsulotomy System in Canada to be June 1, 2018

Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) ("Aequus" or the "Company"), is pleased to announce it will be formally launching the Zepto Precision Pulse Capsulotomy System ("Zepto") in Canada...

AQS.VN : 0.205 (+5.13%)
AQSZF : 0.1529 (+1.93%)
Aequus and Camargo Complete Pre-Investigational New Drug Submission with FDA for Transdermal Anti-Nausea Program

Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced...

AQS.VN : 0.205 (+5.13%)
AQSZF : 0.1529 (+1.93%)
Edible Electronic Circuits Could be a Medical Revolution in the Waiting

FN Media Group Presents USA News Group News Commentary

AQS.VN : 0.205 (+5.13%)
AQSZF : 0.1529 (+1.93%)
BSX : 33.68 (-0.27%)
SUPN : 55.90 (+1.86%)
BDX : 248.13 (+0.45%)
BAX : 74.90 (-0.13%)
CORI : 7.93 (+0.51%)
AXSM : 3.10 (-1.59%)
Aequus Adds Zepto Capsulotomy System, A Revenue Generating Product, to Commercial Ophthalmology Portfolio

Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) ("Aequus" or the "Company"), is pleased to announce it has entered into a commercial agreement with Mynosys Cellular Devices, an ophthalmology focused...

AQS.VN : 0.205 (+5.13%)
AQSZF : 0.1529 (+1.93%)
Aequus Expands Market in Quebec for Tacrolimus IR

Aequus Pharmaceuticals Inc. (TSX-V:AQS) (OTCQB:AQSZF) ("Aequus" or the "Company"), announced today that it has been awarded a three-year contract with Sigma Sante for its partnered product, tacrolimus...

AQS.VN : 0.205 (+5.13%)
AQSZF : 0.1529 (+1.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 0.205
1st Resistance Point 0.200
Last Price 0.205
1st Support Level 0.190
2nd Support Level 0.185

See More

52-Week High 0.450
Fibonacci 61.8% 0.330
Fibonacci 50% 0.292
Fibonacci 38.2% 0.255
Last Price 0.205
52-Week Low 0.135

See More

Business Summary

Aequus Pharmaceuticals Inc is a specialty pharmaceutical company focused on developing and commercializing differentiated products. It offers products like Topiramate XR, Oxcarbazepine XR, Tacrolimus Immediate Release, Vistitan, and other products.

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar